Stock Events

Stock Events

PeptiDream 

M$378.19
17
+M$0.00+0% Tuesday 14:57

Statistics

Day High
378.19
Day Low
378.19
52W High
378.19
52W Low
378.19
Volume
0
Avg. Volume
-
Mkt Cap
49.17B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Aug 11
M$12.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

5NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-1.09
-0.29
0.51
1.31
Expected EPS
-0.7689310918677251
Actual EPS
N/A

Financials

-20.98%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.4BRevenue
-503.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4587N.MX. It's not an investment recommendation.
Mitsubishi UFJ Financial Group
4
8306.TSE
Mitsubishi HC Capital
3
8593.TSE
Microsoft
2
MSFT
Abbvie
2
ABBV

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alnylam Pharmaceuticals
ALNY
Mkt Cap35.61B
Alnylam Pharmaceuticals specializes in RNAi therapeutics, competing in the novel drug discovery space similar to PeptiDream's peptide-based discoveries.
Ionis Pharmaceuticals
IONS
Mkt Cap9.65B
Ionis Pharmaceuticals focuses on RNA-targeted drug discovery, presenting competition in the innovative therapeutic area.
CRISPR Therapeutics
CRSP
Mkt Cap5.39B
CRISPR Therapeutics is a leader in gene editing, a cutting-edge area of biotech where PeptiDream could see indirect competition in drug development.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.88B
BioMarin Pharmaceutical focuses on rare disease treatments, overlapping with PeptiDream's interest in novel, hard-to-treat conditions.
Vertex Pharmaceuticals
VRTX
Mkt Cap138.42B
Vertex Pharmaceuticals is known for its work in treating cystic fibrosis and other serious diseases, areas where PeptiDream's technology could also make an impact.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.22B
Regeneron Pharmaceuticals is a biotech company that develops monoclonal antibodies, a direct competitor in the field of biologic drug development.
AMGEN
AMGN
Mkt Cap236.38B
Amgen is a biopharmaceutical giant with a broad portfolio, including innovative therapeutics that could compete with PeptiDream's developments.
Novo Nordisk
NVO
Mkt Cap205.97B
Novo Nordisk is a global healthcare company with a strong focus on diabetes and obesity, areas where PeptiDream's peptide technology could offer novel treatments.

About

PeptiDream Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative therapeutic solutions, including constrained peptides, small molecules, and peptide-drug conjugates. The company utilizes its exclusive Peptide Discovery Platform System (PDPS), an advanced drug discovery engine, to propel the development of its peptide-based product pipeline. PeptiDream also maintains a collaborative research initiative and an exclusive licensing agreement with Takeda Pharmaceutical Company Limited, specifically focused on developing peptide-drug conjugates for neuromuscular disorders. Founded in 2006, the company's operations are based in Kawasaki, Japan.
Show more...
CEO
Patrick Crawford Reid
Employees
645
Country
Japan
ISIN
JP3836750004

Listings

MX
MX
4587N.MX
OTC Link
US
PPTDF
TSE
JP
4587.TSE

0 Comments

Share your thoughts

FAQ

What is PeptiDream stock price today?▼
The current price of 4587N.MX is M$378.19 MXN — it has increased by +0% in the past 24 hours. Watch PeptiDream stock price performance more closely on the chart.
What is PeptiDream stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Mexican Exchange exchange PeptiDream stocks are traded under the ticker 4587N.MX.
What is PeptiDream market cap?▼
Today PeptiDream has the market capitalization of 49.17B
When is the next PeptiDream earnings date?▼
PeptiDream is going to release the next earnings report on November 05, 2026.
What were PeptiDream earnings last quarter?▼
4587N.MX earnings for the last quarter are -0.93 MXN per share, whereas the estimation was -0.33 MXN resulting in a -178.68% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is PeptiDream revenue for the last year?▼
PeptiDream revenue for the last year amounts to 2.4B MXN.
What is PeptiDream net income for the last year?▼
4587N.MX net income for the last year is -503.61M MXN.
Does PeptiDream pay dividends?▼
Yes, 4587N.MX dividends are paid annual. The last dividend per share was 12.25 MXN. As of today, Dividend Yield (FWD)% is 0%.
How many employees does PeptiDream have?▼
As of September 10, 2026, the company has 645 employees.
In which sector is PeptiDream located?▼
PeptiDream operates in the Health & Wellness sector.
When did PeptiDream complete a stock split?▼
The last stock split for PeptiDream was on June 28, 2017 with a ratio of 2:1.
Where is PeptiDream headquartered?▼
PeptiDream is headquartered in Kawasaki, Japan.